Mental Time Travel and Identity in Bipolar Disorder Patients

NCT ID: NCT02793518

Last Updated: 2016-06-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-05-31

Study Completion Date

2016-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Self-defining memories (SDMs) are memories that are still important today to understand who the investigators are and participate to the maintain of personal identity. SDMs are also linked to our capacity to project ourselves into the future. In bipolar disorder, life events play an important role in the course and outcome of the disease. the study is the first to investigate SDMs and self-defining future projections in a population of remitted patients with bipolar disorder.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study design: case / control study in inclusion prospective, single center. population:

* A group of 30 patients aged 18 to 60 years and followed in the psychiatry department of adult CHU Reims for bipolar disorder type I (DSM-IV criteria).
* A group of 30 control subjects with no personal or family history of severe psychiatric disorder (bipolar disorder, schizophrenia or schizoaffective disorder), recruited from the staff of the University Hospital of Reims, the medical faculty of Reims or Marnais center health promotion of Reims, via the intranet and paper display.

The two groups will be matched for age (± 3 years), sex and educational level (± 2 years).

Plan of investigation: the study will be done in two visits:

* The first visit by a psychiatrist for:

* information on the objectives and the methods of research, verification criteria for inclusion and non-inclusion and participation of obtaining consent (written consent)
* comprehensive psychiatric evaluation and procurement different scales (anxiety scale, Hamilton depression scale, evaluation of verbal IQ, ...).
* 2nd visit, a maximum of 15 days after the first visit by a psychologist, neuropsychologist for the award of the memories of love and future projections defining self: the experimenter asks the subjects to relate memories 3 and 3 future projections. It is important personal events that arouse strong emotions and that the subjects often think.

Memories and projections reported by the subjects are then classified according to their emotional valence, their content, significance and degree of integration itself.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bipolar Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bipolar Disorder patients

Group Type EXPERIMENTAL

psychological tests

Intervention Type BEHAVIORAL

Healthy Controls

Group Type EXPERIMENTAL

psychological tests

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

psychological tests

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

BD patients :

* Men or women, right-handed, with a diagnosis of type 1 bipolar disorder, according to the DSM-IV criteria, aged from 18 to 60 years-old
* Native French speaker
* Affiliated to the social security
* Accepting the study after reading the information note and signing the consentment form

Healthy Controls (HC):

* Men or women, right-handed, aged from 18 to 65 years-old
* Native French speaker
* Affiliated to the social security
* Accepting the study after reading the information note and signing the consentment form

Exclusion Criteria

BD patients :

* A recent alcohol and/or drug abuse or dependence
* A significant general medical illness, including neurological disorders or head trauma
* A sensorial impairment (visual and/or hearing)

HC:

* A personal or first-degree-relative history of bipolar disorder, schizophrenia or schizoaffective disorder according to DSM-IV
* A recent alcohol and/or drug abuse or dependence
* A significant general medical illness, including neurological disorders or head trauma
* A sensorial impairment (visual and/or hearing)
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

CHU de Reims

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chu Reims

Reims, France, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Delphine RAUCHER-CHENE

Role: CONTACT

Sarah BARRIERE

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Delphine RAUCHER-CHENE

Role: primary

Sarah BARRIERE

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PA12064

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Neurofeedback for Bipolar Disorder
NCT05802446 RECRUITING NA
Bipolar Disorder in Late Life
NCT00787930 COMPLETED
Decision-Making in Bipolar Disorder
NCT01463111 COMPLETED NA